Morris Mark Pharmaceuticals Private Limited
About Morris Mark Pharmaceuticals Private Limited
Data last updated:
Morris Mark Pharmaceuticals Private Limited is a private limited company based in Wayanad, Kerala, India. It operates in the manufacturing sector. It was incorporated on 03 September 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U33200KL2020PTC064088.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors including Anjali Puthiyottil and Kozhikkal Surendran Shaji.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mm.26/570 571 572 Club Hill Ima Opposite Manathavady, Wayanad, Kerala, India – 670645.
As per the financials filed for FY 2025, the company reported a revenue of ₹16.08 Lakh, a growth of 60% compared to the previous year. For the same year it recorded a net loss of ₹1.44 Lakh (net margin -9%) and EBITDA of -₹1.31 Lakh (EBITDA margin -8.2%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years.
Company details
Contact details
Morris Mark Pharmaceuticals Private Limited's registered office is in Wayanad, Kerala.
- Registered AddressMm.26/570 571 572 Club Hill Ima Opposite Manathavady, Wayanad, Kerala, India – 670645
- IndustryManufacturing, Manufacturing, Optical & Photographic Instruments
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Morris Mark Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Morris Mark Pharmaceuticals Private Limited, buy the company report.
Financials of Morris Mark Pharmaceuticals Private Limited
FY 2025 filings availableMorris Mark Pharmaceuticals Private Limited reported revenue of ₹16.08 Lakh (up 60% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 7% over three years, including 60% growth in the latest year. EBITDA fell 23% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.31 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.44 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -8.2% | ||||
| Net Profit Margin | -9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Morris Mark Pharmaceuticals Private Limited, buy the company report.
Board of directors of Morris Mark Pharmaceuticals Private Limited
Morris Mark Pharmaceuticals has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anjali Puthiyottil | Director | 20 May 2024 | 2 Years 5 Months | Current |
| Kozhikkal Surendran Shaji | Director | 16 Dec 2025 | 0 Years 10 Months | Current |
| Thormmal Asha | Director | 16 Dec 2025 | 0 Years 10 Months | Current |
Peer comparison
Morris Mark Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Shuban Pharmaceuticals Private Limited | ₹16.17 Lakh (FY 2025) | 62.0% | Bhiwandi, Maharashtra, India | |||
| Morris Mark Pharmaceuticals Private Limitedthis company | ₹16.08 Lakh (FY 2025) | -₹1.44 Lakh | -9% | 60.0% | Wayanad, Kerala, India | |
| Shantakaram Pharmaceuticals Private Limited | ₹16.02 Lakh (FY 2024) | -66.0% | Gwalior, Madhya Pradesh, India | |||
| Sugam Pharmaceuticals Private Limited | ₹16 Lakh (FY 2025) | -2.0% | Muktsar, Punjab, India | |||
| Astrobio Pharmaceuticals Private Limited | ₹15.98 Lakh (FY 2025) | 66.0% | Pune, Maharashtra, India |
To see the full peer comparison of Morris Mark Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Morris Mark Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Morris Mark Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Morris Mark Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Morris Mark Pharmaceuticals Private Limited has 7 board changes on record since 2020: 4 appointments and 3 cessations. The latest: Kozhikkal Surendran Shaji was appointed as Director on 16 Dec 2025.
Frequently asked questions
Morris Mark Pharmaceuticals is an active private limited company based in Wayanad, Kerala, India. The company works in the manufacturing industry. It was incorporated on 03 September 2020 (6+ years old) and is registered under CIN U33200KL2020PTC064088.
Morris Mark Pharmaceuticals has 3 current directors:
- Anjali Puthiyottil - Director
- Kozhikkal Surendran Shaji - Director
- Thormmal Asha - Director
The latest financial statements of Morris Mark Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Morris Mark Pharmaceuticals is U33200KL2020PTC064088. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Morris Mark Pharmaceuticals was incorporated on 03 September 2020, making it 6+ years old. It is registered with the Registrar of Companies, Ernakulam.
The peers of Morris Mark Pharmaceuticals by revenue are Shuban Pharmaceuticals Private Limited, Shantakaram Pharmaceuticals Private Limited, Sugam Pharmaceuticals Private Limited, Astrobio Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Kozhikkal Surendran Shaji was appointed as Director on 16 Dec 2025. Thormmal Asha was appointed as Director on 16 Dec 2025. Aneesh Edathumkunnu ceased to be Managing Director on 20 May 2024. Morris Mark Pharmaceuticals has 7 board changes on record in total.
The registered office of Morris Mark Pharmaceuticals is at Mm.26570 571 572 Club Hill Ima Opposite Manathavady, Wayanad, Kerala, India – 670645.
Morris Mark Pharmaceuticals operates in the manufacturing industry.
Morris Mark Pharmaceuticals can be reached at its registered office: Mm.26570 571 572 Club Hill Ima Opposite Manathavady, Wayanad, Kerala, India – 670645.
Morris Mark Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Ernakulam.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
